Melguizo Alonso, Consolación Author
Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide.
- PRADOS, J
- MELGUIZO, C
- FERNANDEZ, JE
- ARANEGA, AE
- ALVAREZ, L
- ARANEGA, A
Cellular and Molecular Biology - 1/07/1993
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells
- Marchal, JA
- Prados, J
- Melguizo, C
- Fernandez, JE
- Velez, C
- Alvarez, L
- Aranega, A
Journal of Laboratory and Clinical Medicine - 1/07/1997
- JCR Quartile: Q1 (1997)
- JCR Impact Factor: 1.808 (2022)
- Category normalized Impact: 0.621 (1997)
- Scopus
- ORCID
- Web of Science
ACTINOMYCIN-D CAUSES MULTIDRUG-RESISTANCE AND DIFFERENTIATION IN A HUMAN RHABDOMYOSARCOMA CELL-LINE
- MELGUIZO, C
- PRADOS, J
- FERNANDEZ, JE
- VELEZ, C
- ALVAREZ, L
- ARANEGA, A
CELLULAR AND MOLECULAR BIOLOGY - 1/03/1994
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
- Ortiz R.
- Prados J.
- Melguizo C.
- Arias J.
- Adolfina Ruiz M.
- Álvarez P.
- Caba O.
- Luque R.
- Segura A.
- Aránega A.
International Journal of Nanomedicine - 10/2/2012
- SJR Quartile: Q1
- JCR Impact Factor: 3.463 (2012)
- CiteScore: 9.2 (2020)
- SJR: 1.041 (2012
- SNIP: 1.543 (2012
- JCR 5-year Impact Factor: 4.027
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)
5-Fluorouracil-loaded poly(epsilon-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
- Ortiz, Raul
- Prados, Jose
- Melguizo, Consolacion
- Arias, Jose L.
- Ruiz, M. Adolfina
- Alvarez, Pablo J.
- Caba, Octavio
- Luque, Raquel
- Segura, Ana
- Aranega, Antonia
International Journal of Nanomedicine - 10/2/2012
- JCR Quartile: Q1 (2012)
- SJR Quartile: Q1
- JCR Impact Factor: 3.463 (2012)
- Category normalized Impact: 1.681 (2012)
- CiteScore: 7.1 (2019)
- SJR: 1.041 (2012
- SNIP: 1.544 (2012
- JCR 5-year Impact Factor: 4.027
- JCR Categories: NANOSCIENCE & NANOTECHNOLOGY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)
- ORCID
- Web of Science
5-Fluorouracil derivatives: a patent review
- Alvarez, Pablo
- Antonio Marchal, Juan
- Boulaiz, Houria
- Carrillo, Esmeralda
- Velez, Celia
- Rodriguez-Serrano, Fernando
- Melguizo, Consolacion
- Prados, Jose
- Madeddu, Roberto
- Aranega, Antonia
EXPERT OPINION ON THERAPEUTIC PATENTS - 1/02/2012
- SJR Quartile: Q1
- JCR Impact Factor: 3.525 (2012)
- Category normalized Impact: 1.318 (2012)
- CiteScore: 9.8 (2020)
- SJR: 1.33 (2012
- SNIP: 1.119 (2012
- JCR 5-year Impact Factor: 2.523
- JCR Categories: MEDICINE, LEGAL
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)
- Scopus
- ORCID
- Web of Science
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador